ESM1 and nasopharyngeal carcinoma: We divided the NPC cases into 2 groups based on the expression of endocan in tumor cells: endocan-positive (endocan expressed in ≧ 10% of tumor cells) and endocan-negative (endocan expressed in < 10% of tumor cells).